Esqueceu sua senha?
Acomplia Rimonabant Pill Approved in Brazil
|
Liberação de imprensa de:
www.acompliabuy.com
French drugmaker Sanofi-Aventis said on Thursday that its anti-obesity Acomplia drug had received approval from Brazil's health authority.
Acomplia was approved by Brazil for use "as an adjunct to diet and exercise for the treatment of obese patients (BMI more than 30) or overweight patients (BMI more than 27) with associated risk factors, such as type 2 diabetes or dyslipidemia." Brazil thus joins two other large countries, Argentina and Mexico, where the diet drug already is on the market. Sanofi has in the past forecast $3 billion in annual sales from
Acomplia.
for more visit acompliabuy 
Contato:
web:
http://www.acompliabuy.com
E-Mail:
Contate o autor
|
zurück zur Kategorieseite: Internet / Programação
Este artigo foi lido as épocas 838